Elevance Health, Inc. (ELV) Financials
Annual revenue, profitability and per-share results for Elevance Health, Inc., as reported in SEC filings.
Revenue · FY2025
$199.13B
▲ 12.5%YoY
Net income · FY2025
$5.66B
▼ 5.2%YoY
Diluted EPS · FY2025
$25.21
▼ 1.8%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $199.13B | $5.66B | — | $25.21 | $3.17B | 3.6% | +12.5% |
| FY2024 | $177.01B | $5.97B | — | $25.68 | $4.55B | 4.4% | +3.3% |
| FY2023 | $171.34B | $5.99B | — | $25.22 | $6.76B | 5.0% | +9.4% |
| FY2022 | $156.59B | $6.02B | — | $24.81 | $7.25B | 5.4% | +13.0% |
Figures as reported in Elevance Health, Inc.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Financials for companies related to ELV
Never miss a ELV filing.
Get an email when ELV files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.